Regenerative Medicine Market Size & Share Report, 2032

Regenerative Medicine Market - By Type (Cell Therapy, Tissue Engineering, Gene Therapy), By Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology), Global Forecast (2023-2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast calculation

1.4&nbsp;&nbsp;&nbsp; Covid-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Secondary

1.6.1.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.1.2&nbsp;&nbsp;&nbsp;Public sources

1.6.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Regenerative medicine industry 360&ordm; synopsis, 2018 &ndash; 2032 (USD Million)

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Region trends

2.1.3&nbsp;&nbsp;&nbsp; Type trends

2.1.4&nbsp;&nbsp;&nbsp; Application trends

Chapter 3&nbsp;&nbsp;&nbsp;Regenerative Medicine Market Insights

3.1&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032 (USD Million)

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Growing prevalence of chronic diseases worldwide

3.2.1.2&nbsp;&nbsp;&nbsp;Rising investment in development of innovative medicines

3.2.1.3&nbsp;&nbsp;&nbsp;High adoption of stem cell technology in disease treatment

3.2.1.4&nbsp;&nbsp;&nbsp;Strong product pipeline of potential therapies

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory framework

3.2.2.2&nbsp;&nbsp;&nbsp;High cost associated with some regenerative medicine therapy

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By type

3.3.2&nbsp;&nbsp;&nbsp; By application

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Global company market share analysis, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.5&nbsp;&nbsp;&nbsp; Strategic dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Regenerative Medicine Market Estimates and Forecast, By Type, 2018-2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by type

5.2&nbsp;&nbsp;&nbsp; Cell therapy

5.3&nbsp;&nbsp;&nbsp; Tissue engineering

5.4&nbsp;&nbsp;&nbsp; Gene therapy

5.5&nbsp;&nbsp;&nbsp; Other types

Chapter 6&nbsp;&nbsp;&nbsp;Regenerative Medicine Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by application

6.2&nbsp;&nbsp;&nbsp; Oncology

6.3&nbsp;&nbsp;&nbsp; Musculoskeletal

6.4&nbsp;&nbsp;&nbsp; Neurology

6.5&nbsp;&nbsp;&nbsp; Cardiovascular

6.6&nbsp;&nbsp;&nbsp; Wound healing

6.7&nbsp;&nbsp;&nbsp; Ophthalmology

6.8&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Regenerative Medicine Market Estimates and Forecast, By Region, 2018-2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by region

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Spain

7.3.5&nbsp;&nbsp;&nbsp; Italy

7.3.6&nbsp;&nbsp;&nbsp; Sweden

7.3.7&nbsp;&nbsp;&nbsp; The Netherlands

7.3.8&nbsp;&nbsp;&nbsp; Rest of Europe

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; China

7.4.2&nbsp;&nbsp;&nbsp; Japan

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.4.5&nbsp;&nbsp;&nbsp; South Korea

7.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Argentina

7.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

7.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

7.6.1&nbsp;&nbsp;&nbsp; South Africa

7.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.3&nbsp;&nbsp;&nbsp; UAE

7.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa&nbsp;&nbsp;&nbsp;

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Novartis AG

8.2&nbsp;&nbsp;&nbsp; Amgen Inc.

8.3&nbsp;&nbsp;&nbsp; Bristol Myers Squibb

8.4&nbsp;&nbsp;&nbsp; BLUEBIRD BIO

8.5&nbsp;&nbsp;&nbsp; GC Pharma

8.6&nbsp;&nbsp;&nbsp; GlaxoSmithKline plc

8.7&nbsp;&nbsp;&nbsp; ANTEROGEN

8.8&nbsp;&nbsp;&nbsp; BIOSOLUTIONS

8.9&nbsp;&nbsp;&nbsp; TERUMO BCT

8.10&nbsp;&nbsp;&nbsp; AVITA MEDICAL

8.11&nbsp;&nbsp;&nbsp; Smith and Nephew

8.12&nbsp;&nbsp;&nbsp; ORGANOGENESIS

&nbsp;&nbsp;&nbsp;

Regenerative Medicine Market

Get a free sample of this report